Phase 1 study of vibecotamab identifies an optimized dose for treatment of relapsed/refractory acute myeloid leukemia
| Autor: | Ravandi, Farhad, Bashey, Asad, Foran, James, Stock, Wendy, Mawad, Raya, Short, Nicholas, Yilmaz, Musa, Kantarjian, Hagop, Odenike, Olatoyosi, Patel, Anand, Garcha, Raman, Ainsworth, William Barrett, Clynes, Raphael, Kanodia, Jitendra, Ding, Ying, Li, Huajiang, Kye, Steve, Mims, Alice |
|---|---|
| Zdroj: | In Blood Advances 14 November 2023 7(21):6492-6505 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|